"Devazepide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A derivative of benzodiazepine that acts on the cholecystokinin A (CCKA) receptor to antagonize CCK-8's (SINCALIDE) physiological and behavioral effects, such as pancreatic stimulation and inhibition of feeding.
| Descriptor ID |
D020109
|
| MeSH Number(s) |
D03.633.100.079.080.070.200
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Devazepide".
Below are MeSH descriptors whose meaning is more specific than "Devazepide".
This graph shows the total number of publications written about "Devazepide" by people in this website by year, and whether "Devazepide" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Devazepide" by people in Profiles.
-
Cholecystokinin receptors do not mediate the suppression of food-motivated behavior by lipopolysaccharide and interleukin-1 beta in mice. Physiol Behav. 2000 May; 69(3):325-31.
-
Cholecystokinin receptors do not mediate the behavioral effects of lipopolysaccharide in mice. Physiol Behav. 1997 Aug; 62(2):385-9.
-
Stimulation of both CCK-A and CCK-B receptors activates MAP kinases in AR42J and receptor-transfected CHO cells. Digestion. 1997; 58(4):361-7.
-
Effects of bombesin on pancreatic digestive enzyme gene expression. Endocrinology. 1992 Mar; 130(3):1451-8.
-
Pancreatic digestive enzyme gene expression: effects of CCK and soybean trypsin inhibitor. Am J Physiol. 1989 Apr; 256(4 Pt 1):G733-8.